Skip to main content

Dec
8
2011

"I.B.M.’s Strategic Intellectual Property Insight Platform. Clearly, the Watson branding team didn’t work on this name.

But then again, this isn’t for television, where Watson performed. It is for major corporate customers, seeking competitive advantage. The technology, sold as a cloud-based service, is the result of several years of joint development between IBM Research and four companies — AstraZeneca, Bristol-Myers Squibb, DuPont and Pfizer.

The insight platform uses data mining, natural-language processing and analytics to pore through millions of patent filings and biomedical journals to look for chemical compounds used in drug discovery."

ibm watson pharma bigdata

1 - 1 of 1
Showing 20 items per page

Highlighter, Sticky notes, Tagging, Groups and Network: integrated suite dramatically boosting research productivity. Learn more »

Join Diigo
Move to top